Early screening for Alzheimer’s disease: a scientific, ethical, and value-based framework for targeted screening in at-risk individuals

[thumbnail of Xu and Carro - Final.pdf]
Text
- Accepted Version
· Restricted to Repository staff only until 14 November 2026.
[thumbnail of Xu and Carro - Final.docx]
Text
- Accepted Version
· Restricted to Repository staff only

Please see our End User Agreement.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email

Xu, F. ORCID: https://orcid.org/0000-0002-3489-6824 and Carro, E. (2025) Early screening for Alzheimer’s disease: a scientific, ethical, and value-based framework for targeted screening in at-risk individuals. Med, 6 (11). 100919. ISSN 2666-6340 doi: 10.1016/j.medj.2025.100919

Abstract/Summary

Although curative therapies for Alzheimer's disease (AD) remain elusive, recent approval of disease-modifying treatments and advances of less- or non-invasive biomarkers have shifted the paradigm toward earlier detection, including asymptomatic individuals. Here, we propose a multidisciplinary framework, integrating scientific evidence, ethical principles, and value-based health care, to guide the responsible development and deployment of early detection programs for AD.

Altmetric Badge

Dimensions Badge

Item Type Article
URI https://centaur.reading.ac.uk/id/eprint/127166
Identification Number/DOI 10.1016/j.medj.2025.100919
Refereed Yes
Divisions Arts, Humanities and Social Science > School of Politics, Economics and International Relations > Economics
Publisher Cell Press
Download/View statistics View download statistics for this item

University Staff: Request a correction | Centaur Editors: Update this record